Skip to main content

Table 1 Demographic data of ME/CFS and healthy control patients

From: Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  ME/CFS patients Healthy control subjects
Male/Female 0/49 0/25
Age (years) 49.4 ± 1.9 51.1 ± 2.7
BMI (kg/m2) 23.3 ± 0.5 23.4 ± 0.6
Physical Health
 Physical Functioning 40.6 ± 3.9* 95.3 ± 1.4
 Role-Physical 7.7 ± 3.1* 96.9 ± 2.2
 Pain 55.9 ± 3.6* 90.0 ± 1.8
 General Health 25.2 ± 2.3* 81.8 ± 2.4
Mental Health
 Energy 16.9 ± 2.3* 71.7 ± 2.5
 Social Functioning 33.0 ± 3.7* 91.9 ± 2.4
 Role-Emotional 71.4 ± 5.9 84.5 ± 5.4
 Emotion 73.2 ± 2.4* 80.6 ± 2.6
Age ME/CFS of first symptoms (years) 31.0 ± 1.8 N/A
Age of ME/CFS diagnosis (years) 37.1 ± 1.7 N/A
Sudden/Gradual ME/CFS onset 33/16 N/A
  1. Average demographic information and RAND-36 scores with standard error of ME/CFS and healthy controls included in this cohort. * = p ≤ 0.05, t-test